Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.
作者： Aron Goldhirsch , John H. Glick , Richard D. Gelber , Alan S. Coates , Hans-Jörg Senn
DOI: 10.1200/JCO.2001.19.18.3817
关键词: Medicine 、 Internal medicine 、 Adjuvant therapy 、 Primary breast cancer 、 Oncology
摘要:
sci-hub.se 参考文章(56)
Early Breast Cancer Trialists' Collaborative Group, None, Polychemotherapy for early breast cancer: an overview of the randomised trials The Lancet. ,vol. 352, pp. 930- 942 ,(1998) , 10.1016/S0140-6736(98)03301-7
Tamoxifen for early breast cancer: An overview of the randomised trials The Lancet. ,vol. 351, pp. 1451- 1467 ,(1998) , 10.1016/S0140-6736(97)11423-4
E. Engelsman, J.C.M. Klijn, R.D. Rubens, J. Wildiers, L.V.A.M. Beex, M.A. Nooij, N. Rotmensz, R. Sylvester, “Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer European Journal of Cancer and Clinical Oncology. ,vol. 27, pp. 966- 970 ,(1991) , 10.1016/0277-5379(91)90259-G
Jack Cuzick, Future possibilities in the prevention of breast cancer: Breast cancer prevention trials Breast Cancer Research. ,vol. 2, pp. 258- 263 ,(2000) , 10.1186/BCR66
Milvia Zambetti, Angela Moliterni, Carlo Materazzo, Marco Stefanelli, Sonia Cipriani, Pinuccia Valagussa, Gianni Bonadonna, Luca Gianni, Long-Term Cardiac Sequelae in Operable Breast Cancer Patients Given Adjuvant Chemotherapy With or Without Doxorubicin and Breast Irradiation Journal of Clinical Oncology. ,vol. 19, pp. 37- 43 ,(2001) , 10.1200/JCO.2001.19.1.37
J. G.M. Klijn, R.W. Blamey, F. Boccardo, T. Tominaga, L. Duchateau, R. Sylvester, Combined Tamoxifen and Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Versus LHRH Agonist Alone in Premenopausal Advanced Breast Cancer: A Meta-Analysis of Four Randomized Trials Journal of Clinical Oncology. ,vol. 19, pp. 343- 353 ,(2001) , 10.1200/JCO.2001.19.2.343
B Fisher, C Redmond, A Brown, E R Fisher, N Wolmark, D Bowman, D Plotkin, J Wolter, R Bornstein, S Legault-Poisson, Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial. Journal of Clinical Oncology. ,vol. 4, pp. 459- 471 ,(1986) , 10.1200/JCO.1986.4.4.459
M N Levine, V H Bramwell, K I Pritchard, B D Norris, L E Shepherd, H Abu-Zahra, B Findlay, D Warr, D Bowman, J Myles, A Arnold, T Vandenberg, R MacKenzie, J Robert, J Ottaway, M Burnell, C K Williams, D Tu, Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology. ,vol. 16, pp. 2651- 2658 ,(1998) , 10.1200/JCO.1998.16.8.2651
Jennet M. Harvey, Gary M. Clark, C. Kent Osborne, D. Craig Allred, Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer Journal of Clinical Oncology. ,vol. 17, pp. 1474- 1474 ,(1999) , 10.1200/JCO.1999.17.5.1474
Marco Colleoni, Marco Bonetti, Alan S. Coates, Monica Castiglione-Gertsch, Richard D. Gelber, Karen Price, Carl-Magnus Rudenstam, Jurij Lindtner, John Collins, Beat Thürlimann, Stig Holmberg, Andrea Veronesi, Giovanni Marini, Aron Goldhirsch, , Early Start of Adjuvant Chemotherapy May Improve Treatment Outcome for Premenopausal Breast Cancer Patients With Tumors not Expressing Estrogen Receptors Journal of Clinical Oncology. ,vol. 18, pp. 584- 590 ,(2000) , 10.1200/JCO.2000.18.3.584